TGFB1 and chronic obstructive pulmonary disease: Annual decline in FEV1 according to genotypes of TGF-β1 and decorin. Changes in decline between genotypes in the total population and in subjects who developed COPD (GOLD stage II or higher; FEV1/VC<70%, FEV1<80% predicted) are presented.